BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 17218018)

  • 1. PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease.
    Alkon DL; Sun MK; Nelson TJ
    Trends Pharmacol Sci; 2007 Feb; 28(2):51-60. PubMed ID: 17218018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin, PKC signaling pathways and synaptic remodeling during memory storage and neuronal repair.
    Nelson TJ; Sun MK; Hongpaisan J; Alkon DL
    Eur J Pharmacol; 2008 May; 585(1):76-87. PubMed ID: 18402935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3beta, or a link between amyloid and tau pathology?
    Muyllaert D; Kremer A; Jaworski T; Borghgraef P; Devijver H; Croes S; Dewachter I; Van Leuven F
    Genes Brain Behav; 2008 Feb; 7 Suppl 1():57-66. PubMed ID: 18184370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of protein kinase C activators: cognition-enhancing and antidementic therapeutics.
    Sun MK; Alkon DL
    Pharmacol Ther; 2010 Jul; 127(1):66-77. PubMed ID: 20382181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C activators as synaptogenic and memory therapeutics.
    Sun MK; Alkon DL
    Arch Pharm (Weinheim); 2009 Dec; 342(12):689-98. PubMed ID: 19899099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Protein kinase C].
    Matsushima H; Shimohama S
    Nihon Rinsho; 1995 May; 53(5):1282-6. PubMed ID: 7602792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in Alzheimer's disease drug discovery: an update.
    Williams M
    Curr Opin Investig Drugs; 2009 Jan; 10(1):23-34. PubMed ID: 19127484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodegeneration and Alzheimer's disease: the lesson from tauopathies.
    Sorrentino G; Bonavita V
    Neurol Sci; 2007 Apr; 28(2):63-71. PubMed ID: 17464468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients.
    Battaini F; Pascale A; Lucchi L; Pasinetti GM; Govoni S
    Exp Neurol; 1999 Oct; 159(2):559-64. PubMed ID: 10506528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of protein kinase C isozymes for the treatment of dementias.
    Sun MK; Alkon DL
    Adv Pharmacol; 2012; 64():273-302. PubMed ID: 22840750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for protein kinase C in associative learning.
    Olds JL; Alkon DL
    New Biol; 1991 Jan; 3(1):27-35. PubMed ID: 2039766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
    Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
    Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein kinase C as a peripheral biomarker for Alzheimer's disease.
    de Barry J; Liégeois CM; Janoshazi A
    Exp Gerontol; 2010 Jan; 45(1):64-9. PubMed ID: 19895879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Ionic channels and second messenger alterations in Alzheimer's disease. Relevance of studies in nonneuronal cells].
    Etcheberrigaray R; Ibarreta D
    Rev Neurol; 2001 Oct 16-31; 33(8):740-9. PubMed ID: 11784972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abeta(1-42) stimulated T cells express P-PKC-delta and P-PKC-zeta in Alzheimer disease.
    Miscia S; Ciccocioppo F; Lanuti P; Velluto L; Bascelli A; Pierdomenico L; Genovesi D; Di Siena A; Santavenere E; Gambi F; Ausili-Cèfaro G; Grimley PM; Marchisio M; Gambi D
    Neurobiol Aging; 2009 Mar; 30(3):394-406. PubMed ID: 17850925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA receptor-dependent signaling pathways that underlie amyloid beta-protein disruption of LTP in the hippocampus.
    Yamin G
    J Neurosci Res; 2009 Jun; 87(8):1729-36. PubMed ID: 19170166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
    Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
    Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin and cholesterol pathways in neuronal function, memory and neurodegeneration.
    Nelson TJ; Alkon DL
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1033-6. PubMed ID: 16246039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The "memory kinases": roles of PKC isoforms in signal processing and memory formation.
    Sun MK; Alkon DL
    Prog Mol Biol Transl Sci; 2014; 122():31-59. PubMed ID: 24484697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of presenilin function causes Alzheimer's disease-like neurodegeneration in the mouse.
    Chen Q; Nakajima A; Choi SH; Xiong X; Tang YP
    J Neurosci Res; 2008 May; 86(7):1615-25. PubMed ID: 18189321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.